Nvision Imaging
4 known investors
Find your way into Nvision Imaging
NVision develops quantum computing and quantum-enhanced sensing platforms based on quantum spin control in organic molecules, with focus on healthcare applications including drug development and disease treatment.
Also known as NVision · NVision Imaging Technologies · NVision Quantum Technologies
Investors · 4
Company profile
researched Aug 2026NVision (also referred to as NVision Quantum Technologies) is a quantum technology company headquartered in Ulm, Germany, that engineers the quantum properties of organic molecules. Its stated approach is to push complexity into the molecular level rather than into hardware, producing controllable quantum systems intended to be scalable.
The company operates two technology lines. POLARIS is a quantum-enhanced MRI platform that boosts the magnetic signal of engineered sugar molecules by more than 10,000 times, making them visible to MRI and enabling real-time imaging of disease metabolism; the company states POLARIS is being deployed to research centers internationally. PIQC is a quantum computing platform based on molecular quantum nodes native to photonic chips, in which engineered organic molecules are intended to combine long-lived qubits with intrinsic photonic interfaces. According to the company, research into molecules for metabolic imaging led to the discovery of a new type of molecular qubit, which underpins the quantum computing effort.
Founding story
NVision was co-founded by Dr. Sella Brosh, who has served as CEO since the company's inception in 2016. Brosh was previously a senior engagement manager at McKinsey & Company's US Mid-Atlantic office, leading commercialization work for pharmaceutical and medical device clients. Ilai Schwartz, PhD, a McKinsey alumnus with an MSc in physics from the Hebrew University of Jerusalem and a PhD from Ulm University, serves as CTO and is an inventor of concepts in quantum hyperpolarization; he led the development of what the company describes as the first viable room-temperature polarizer for metabolic MRI. Scientific co-founders and affiliated academics include Prof. Martin B. Plenio and Prof. Fedor Jelezko of Ulm University and Prof. Alex Retzker of the Hebrew University of Jerusalem.
Traction
The company states that its POLARIS quantum-enhanced MRI system is already being deployed to leading research centers globally. In 2026 it announced an expansion of its quantum platform into South Korea, and its molecular qubit work was covered by broadcaster SWR and featured in a Quantum Machines seminar series.
Latest developments
In July 2026 NVision announced an expansion of its quantum platform into South Korea. In August 2026, CTO Ilai Schwartz presented NVision's molecular spin qubit results in a Quantum Machines seminar, and SWR profiled the company's transition from quantum-enhanced MRI toward molecular quantum computing.
▸Full profile — market position, technology, go-to-market, geography
Market position
Positions itself as pursuing the first quantum computing platform based on molecular quantum nodes native to photonic chips, alongside a quantum signal-enhancement product for MRI.
Technology
NVision's technology centers on quantum spin control in engineered organic molecules. The POLARIS platform uses room-temperature hyperpolarization to increase the magnetic signal of engineered sugar molecules by over 10,000x for metabolic MRI. The PIQC platform uses molecular quantum nodes native to photonic chips, combining long-lived molecular spin qubits with intrinsic photonic interfaces. Work described by the company and its CTO includes individual addressing and coherent control of single molecular spin qubits, millisecond-scale coherence and optical spin readout, and integration of molecular qubits with photonic platforms for quantum computing and networking.
Go-to-market
Research centers and academic institutions conducting metabolic MRI and hyperpolarized magnetic resonance research; the healthcare and life-sciences domain more broadly.
Geography
Headquartered in Ulm, Germany, with scientific ties to Ulm University and the Hebrew University of Jerusalem. POLARIS systems are described as being deployed to leading research centers globally, and in July 2026 the company announced expansion into South Korea.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 3
launches, deals, and filingsGerman broadcaster SWR profiled NVision's path from quantum-enhanced MRI to quantum computing, including the discovery of a new type of molecular qubit arising from research into molecules for metabolic imaging.
Quantum Machines featured NVision CTO Ilai Schwartz in an on-demand seminar covering the first individual addressing and coherent control of single molecular spin qubits, millisecond-scale coherence, optical spin readout, and integration with photonic platforms.
NVision announced an expansion of its quantum platform into South Korea.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 1
primary sources listed
- Nvision Imagingnvision-imaging.com · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Nvision Imaging do?
- NVision engineers organic molecules into quantum systems for quantum-enhanced MRI and photonic molecular quantum computing.
- Who are Nvision Imaging's investors?
- Nvision Imaging's investors include Entrée Capital, Lauder Partners, Matterwave Ventures, Playground Global.